Search hospitals > Connecticut > Bridgeport
Hartford HealthCare - Saint Vincent's Medical Center
Claim this profileBridgeport, Connecticut 06606
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Serous Cystadenocarcinoma
Conducts research for Ovarian Carcinoma
15 reported clinical trials
3 medical researchers
Summary
Hartford HealthCare - Saint Vincent's Medical Center is a medical facility located in Bridgeport, Connecticut. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Serous Cystadenocarcinoma, Ovarian Carcinoma and other specialties. Hartford HealthCare - Saint Vincent's Medical Center is involved with conducting 15 clinical trials across 47 conditions. There are 3 research doctors associated with this hospital, such as Rajani Nadkarni, MD, Alvaro G. Menendez, and Christopher M. Iannuzzi.Area of expertise
1Cancer
HER2 positive
ER negative
PR negative
2Breast Cancer
HER2 positive
ER positive
ER negative
Top PIs
Rajani Nadkarni, MDHartford Hospital4 years of reported clinical research
Studies Breast Cancer
2 reported clinical trials
5 drugs studied
Alvaro G. MenendezHartford Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
1 reported clinical trial
2 drugs studied
Christopher M. IannuzziHartford HealthCare - Saint Vincent's Medical Center3 years of reported clinical research
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
2 reported clinical trials
14 drugs studied
Clinical Trials running at Hartford HealthCare - Saint Vincent's Medical Center
Breast Cancer
Prostate Cancer
Prostate Adenocarcinoma
Tumors
Bone Metastasis
Adenocarcinoma
Recurrence
Cancer
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hartford HealthCare - Saint Vincent's Medical Center?
Hartford HealthCare - Saint Vincent's Medical Center is a medical facility located in Bridgeport, Connecticut. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Serous Cystadenocarcinoma, Ovarian Carcinoma and other specialties. Hartford HealthCare - Saint Vincent's Medical Center is involved with conducting 15 clinical trials across 47 conditions. There are 3 research doctors associated with this hospital, such as Rajani Nadkarni, MD, Alvaro G. Menendez, and Christopher M. Iannuzzi.